Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TP 110

Known as: TP-110, TP110 compound 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
TP-110, a novel proteasome inhibitor, has been found to possess potent growth inhibition in human multiple myeloma cells. To… Expand
Is this relevant?
2009
2009
TP-110, a new proteasome inhibitor, has previously shown potent growth inhibition in various tumor cell lines. In this study, the… Expand
Is this relevant?
2009
2009
Boronic acid derivatives of tyropeptin were synthesized with TP-110 as the lead compound. Due to the lability of the aminoboronic… Expand
Is this relevant?
2007
2007
Proteasome inhibitors are useful in the treatment of cancer. Recently, we found a new proteasome inhibitor, TP-110, derived from… Expand
Is this relevant?
2005
2005
Tyropeptin A, a new potent proteasome inhibitor, was produced by Kitasatospora sp. MK993-dF2. To enhance the inhibitory potency… Expand
Is this relevant?
2005
2005
Tyropeptin A, a potent proteasome inhibitor, was isolated from the culture broth of Kitasatospora sp. MK993-dF2. We synthesized… Expand
Is this relevant?
2005
2005
Tyropeptin A, a potent proteasome inhibitor, was isolated from the culture broth of Kitasatospora sp. MK993-dF2. We synthesized… Expand
  • table 1
  • table 2
Is this relevant?